Search research articles
Contact Us
Filters
Showing results (251-260 of 262) with videos related to
Page
of 27
Sort By:
Nature Communications
|
December 31, 2024
NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression
Tejaswini Reddy, Akshjot Puri, Liliana Guzman-Rojas, et al.
Cancer Research Communications
|
June 28, 2023
Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer
Xuemei Xie, Gaurav B Chauhan, Ramakrishna Edupuganti, et al.
JCO Precision Oncology
|
March 16, 2022
Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy
Hiroko Masuda, Kenichi Harano, Sakiko Miura, et al.
Cancer Research
|
May 14, 2009
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics
Bryan T Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke-Hale, et al.
British Journal of Cancer
|
June 29, 2022
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk
Mathilde M Almekinders, Tycho Bismeijer, Tapsi Kumar, et al.
Human Pathology
|
January 22, 2022
Expression of TRPS1 in phyllodes tumor and sarcoma of the breast
Jing Wang, Wei-Lien Wang, Hongxia Sun, et al.
JAMA Oncology
|
June 8, 2018
Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer
Naoko Matsuda, Xiaoping Wang, Bora Lim, et al.
The Journal of Molecular Diagnostics : JMD
|
February 12, 2017
Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial
Chih-Jian Lih, Robin D Harrington, David J Sims, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 30, 2016
Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes
Andrey S Dobroff, Sara D'Angelo, Bedrich L Eckhardt, et al.
Nature Communications
|
July 21, 2023
Obesity-associated changes in molecular biology of primary breast cancer
Ha-Linh Nguyen, Tatjana Geukens, Marion Maetens, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 262) with videos related to
Sort By:
Page
of 27
Nature Communications
|
December 31, 2024
NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression
Tejaswini Reddy, Akshjot Puri, Liliana Guzman-Rojas, et al.
Cancer Research Communications
|
June 28, 2023
Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer
Xuemei Xie, Gaurav B Chauhan, Ramakrishna Edupuganti, et al.
JCO Precision Oncology
|
March 16, 2022
Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy
Hiroko Masuda, Kenichi Harano, Sakiko Miura, et al.
Cancer Research
|
May 14, 2009
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics
Bryan T Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke-Hale, et al.
British Journal of Cancer
|
June 29, 2022
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk
Mathilde M Almekinders, Tycho Bismeijer, Tapsi Kumar, et al.
Human Pathology
|
January 22, 2022
Expression of TRPS1 in phyllodes tumor and sarcoma of the breast
Jing Wang, Wei-Lien Wang, Hongxia Sun, et al.
JAMA Oncology
|
June 8, 2018
Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer
Naoko Matsuda, Xiaoping Wang, Bora Lim, et al.
The Journal of Molecular Diagnostics : JMD
|
February 12, 2017
Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial
Chih-Jian Lih, Robin D Harrington, David J Sims, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 30, 2016
Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes
Andrey S Dobroff, Sara D'Angelo, Bedrich L Eckhardt, et al.
Nature Communications
|
July 21, 2023
Obesity-associated changes in molecular biology of primary breast cancer
Ha-Linh Nguyen, Tatjana Geukens, Marion Maetens, et al.
Page
of 27